KENACOMB ONT 2.5 MG
NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG NYSTATIN : 100000 UNIT GRAMICIDIN : .25 MG TRIAMCINOLONE ACETONIDE : 1 MG · DIN 00245267 · SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is KENACOMB ONT?
KENACOMB ONT 2.5 MG contains NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG NYSTATIN : 100000 UNIT GRAMICIDIN : .25 MG TRIAMCINOLONE ACETONIDE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00245267, held by SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00245267 |
|---|---|
| Brand name | KENACOMB ONT |
| Generic / active ingredient | NEOMYCIN (NEOMYCIN SULFATE) : 2.5 MG NYSTATIN : 100000 UNIT GRAMICIDIN : .25 MG TRIAMCINOLONE ACETONIDE : 1 MG |
| Manufacturer | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. |
| Strength | 2.5 MG |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07CB01 TRIAMCINOLONE AND ANTIBIOTICS |
| AHFS class | 84:06.00 ; 84:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Aug-1997 |
| Original market date | 1965-12-31 00:00:00 |
Is TRIAMCINOLONE AND ANTIBIOTICS in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by STERIMAX INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code D07CB01 TRIAMCINOLONE AND ANTIBIOTICS. 4 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-TRIACOMB | 100000 UNIT | CREAM | TEVA CANADA LIMITED | MARKETED | DIN 00550507 |
| THERADERM CREAM | 2.5 MG | CREAM | BIMEDA-MTC ANIMAL HEALTH INC | MARKETED | DIN 02022818 |
| VIADERM KC CRM | 0.10% | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00717002 |
| VIADERM KC ONT | 2.5 MG | OINTMENT | TARO PHARMACEUTICALS INC | MARKETED | DIN 00717029 |
| ARISTOFORM R CRM 0.1% | 1 MG | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00128058 |
| KENACOMB CREAM | 2.5 MG | CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999850 |
| KENACOMB MILD CREAM | 2.5 MG | CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999842 |
| KENACOMB MILD OINTMENT | .25 MG | OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999834 |
| KENACOMB OINTMENT | .25 MG | OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999826 |
| MECOMB CRM 0.1% | .25 MG | CREAM | MEDIC LABORATORY LTÉE | CANCELLED POST MARKET | DIN 00464554 |
Who else supplies TRIAMCINOLONE AND ANTIBIOTICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIAMCINOLONE AND ANTIBIOTICS appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.